Immatics (IMTX) Non Operating Income (2019 - 2025)

Immatics recorded quarterly Non Operating Income of $3.9 million in Q4 2025, down 16.62% quarter-over-quarter from $4.6 million in Q3 2025, and down 91.47% year-over-year from $45.3 million in Q4 2024.

Immatics' Non Operating Income history runs 7 years deep, the most recent figure standing at $3.9 million for Q4 2025.

  • In Q4 2025, Non Operating Income fell 91.47% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at -$17.9 million (down 127.84% YoY), while the FY2025 annual figure was -$18.6 million, down 128.95% from the prior year.
  • Non Operating Income came in at $3.9 million for Q4 2025 at Immatics, down from $4.6 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $45.3 million in Q4 2024 to a low of -$20.6 million in Q2 2025.
  • A 5-year average of $2.9 million and a median of $1.6 million in 2022 frame the typical range for Non Operating Income.
  • Across the five-year window, Non Operating Income plunged 1182.94% in 2022 and jumped 2587.02% in 2024, its largest moves.
  • Immatics' Non Operating Income stood at -$831666.9 in 2021, then slumped by 1182.94% to -$10.7 million in 2022, then surged by 115.79% to $1.7 million in 2023, then surged by 2587.02% to $45.3 million in 2024, then tumbled by 91.47% to $3.9 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods registered $3.9 million, $4.6 million, and -$20.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 444,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 201.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -46.98 Mn
10 Immatics 1.80 Bn 1.80 Bn - 3.86 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.86 Mn
Sep 30, 2025 4.63 Mn
Jun 30, 2025 -20.63 Mn
Mar 31, 2025 -5.76 Mn
Dec 31, 2024 45.27 Mn
Sep 30, 2024 -3.15 Mn
Jun 30, 2024 9.38 Mn
Mar 31, 2024 12.76 Mn
Dec 31, 2023 1.68 Mn
Sep 30, 2023 7.38 Mn
Jun 30, 2023 -11.21 Mn
Mar 31, 2023 7.17 Mn
Dec 31, 2022 -10.67 Mn
Sep 30, 2022 1.56 Mn
Jun 30, 2022 4.08 Mn
Mar 31, 2022 19.27 Mn
Dec 31, 2021 -831,666.88
Sep 30, 2021 -4.96 Mn
Jun 30, 2021 -3.78 Mn
Mar 31, 2021 1.24 Mn
Dec 31, 2020 2.46 Mn
Sep 30, 2020 -169.56 Mn
Jun 30, 2020 -1.90 Mn
Mar 31, 2020 2.98 Mn
Dec 31, 2019 4.10 Mn
Sep 30, 2019 3.10 Mn
Jun 30, 2019 -400,015.52